Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts
- PMID: 20569276
- PMCID: PMC3823123
- DOI: 10.1111/j.1582-4934.2008.00671.x
Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts
Abstract
We recently demonstrated that blood-brain barrier permeabilization using mannitol enhances the therapeutic efficacy of systemically administered human umbilical cord blood (HUCB) by facilitating the entry of neurotrophic factors from the periphery into the adult stroke brain. Here, we examined whether the same blood-brain barrier manipulation approach increases the therapeutic effects of intravenously delivered HUCB in a neonatal hypoxic-ischaemic (HI) injury model. Seven-day-old Sprague-Dawley rats were subjected to unilateral HI injury and then at day 7 after the insult, animals intravenously received vehicle alone, mannitol alone, HUCB cells (15k mononuclear fraction) alone or a combination of mannitol and HUCB cells. Behavioural tests at post-transplantation days 7 and 14 showed that HI animals that received HUCB cells alone or when combined with mannitol were significantly less impaired in motor asymmetry and motor coordination compared with those that received vehicle alone or mannitol alone. Brain tissues from a separate animal cohort from the four treatment conditions were processed for enzyme-linked immunosorbent assay at day 3 post-transplantation, and revealed elevated levels of GDNF, NGF and BDNF in those that received HUCB cells alone or when combined with mannitol compared with those that received vehicle or mannitol alone, with the combined HUCB cells and mannitol exhibiting the most robust neurotropic factor up-regulation. Histological assays revealed only sporadic detection of HUCB cells, suggesting that the trophic factor-mediated mechanism, rather than cell replacement per se, principally contributed to the behavioural improvement. These findings extend the utility of blood-brain barrier permeabilization in facilitating cell therapy for treating neonatal HI injury.
Figures




Similar articles
-
Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke.Stroke. 2004 Oct;35(10):2385-9. doi: 10.1161/01.STR.0000141680.49960.d7. Epub 2004 Sep 2. Stroke. 2004. PMID: 15345799
-
Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury.Cell Transplant. 2006;15(3):231-8. doi: 10.3727/000000006783982034. Cell Transplant. 2006. PMID: 16719058
-
Intra-arterial transplantation of human umbilical cord blood mononuclear cells in neonatal hypoxic-ischemic rats.Life Sci. 2014 Feb 6;96(1-2):33-9. doi: 10.1016/j.lfs.2013.10.017. Epub 2013 Oct 28. Life Sci. 2014. PMID: 24177600
-
The therapeutic potential of human umbilical cord blood transplantation for neonatal hypoxic-ischemic brain injury and ischemic stroke.Acta Med Okayama. 2012;66(6):429-34. doi: 10.18926/AMO/48962. Acta Med Okayama. 2012. PMID: 23254576 Review.
-
Mannitol-enhanced delivery of stem cells and their growth factors across the blood-brain barrier.Cell Transplant. 2014;23(4-5):531-9. doi: 10.3727/096368914X678337. Epub 2014 Jan 29. Cell Transplant. 2014. PMID: 24480552 Free PMC article. Review.
Cited by
-
Factors Influencing the Efficacy of Umbilical Cord Blood-Derived Cell Therapy for Perinatal Brain Injury.Stem Cells Transl Med. 2023 Mar 17;12(3):125-139. doi: 10.1093/stcltm/szad006. Stem Cells Transl Med. 2023. PMID: 36847059 Free PMC article.
-
Group II Metabotropic Glutamate Receptors Reduce Apoptosis and Regulate BDNF and GDNF Levels in Hypoxic-Ischemic Injury in Neonatal Rats.Int J Mol Sci. 2022 Jun 23;23(13):7000. doi: 10.3390/ijms23137000. Int J Mol Sci. 2022. PMID: 35806000 Free PMC article.
-
Systemic injection of CD34(+)-enriched human cord blood cells modulates poststroke neural and glial response in a sex-dependent manner in CD1 mice.Stem Cells Dev. 2015 Jan 1;24(1):51-66. doi: 10.1089/scd.2014.0135. Stem Cells Dev. 2015. PMID: 25121827 Free PMC article.
-
Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response.Cell Mol Immunol. 2017 Aug;14(8):693-701. doi: 10.1038/cmi.2015.99. Epub 2015 Dec 28. Cell Mol Immunol. 2017. PMID: 26707403 Free PMC article.
-
Immunomodulatory Mechanism and Potential Therapies for Perinatal Hypoxic-Ischemic Brain Damage.Front Pharmacol. 2020 Dec 11;11:580428. doi: 10.3389/fphar.2020.580428. eCollection 2020. Front Pharmacol. 2020. PMID: 33536907 Free PMC article. Review.
References
-
- Blau H, Brazelton T, Keshet G, et al. Something in the eye of the beholder. Science. 2002;298:361–2. - PubMed
-
- Mezey E, Nagy A, Szalayova I, et al. Comment on “Failure of bone marrow cells to transdifferentiate into neural cells in vivo”. Science. 2003;299:1184. - PubMed
-
- Theise ND, Krause DS, Sharkis S. Comment on “Little evidence for developmental plasticity of adult hematopoietic stem cells”. Science. 2003;299:1317. - PubMed
-
- Wagers AJ, Sherwood RI, Christensen JL, et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002;297:2256–9. - PubMed
-
- Castro RF, Jackson KA, Goodell MA, et al. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science. 2002;297:1299. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources